VivoSim Labs, Inc.
VIVS
$1.98
$0.158.20%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 37.00K | 51.00K | 24.00K | 30.00K | 39.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 37.00K | 51.00K | 24.00K | 30.00K | 39.00K |
| Cost of Revenue | 13.00K | 859.00K | 1.78M | 985.00K | 28.00K |
| Gross Profit | 24.00K | -808.00K | -1.76M | -955.00K | 11.00K |
| SG&A Expenses | 1.95M | 2.35M | 1.71M | 1.65M | 2.02M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.95M | 3.21M | 3.49M | 2.64M | 3.43M |
| Operating Income | -2.92M | -3.15M | -3.47M | -2.61M | -3.39M |
| Income Before Tax | -2.84M | 6.85M | -3.45M | -2.55M | -3.34M |
| Income Tax Expenses | -- | 0.00 | -- | -- | 2.00K |
| Earnings from Continuing Operations | -2.84M | 6.85M | -3.45M | -2.55M | -3.34M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.84M | 6.85M | -3.45M | -2.55M | -3.34M |
| EBIT | -2.92M | -3.15M | -3.47M | -2.61M | -3.39M |
| EBITDA | -2.85M | -3.09M | -3.40M | -2.54M | -3.32M |
| EPS Basic | -1.14 | 4.21 | -2.48 | -1.84 | -2.74 |
| Normalized Basic EPS | -0.71 | -1.21 | -1.55 | -1.15 | -1.71 |
| EPS Diluted | -1.14 | 4.21 | -2.48 | -1.84 | -2.74 |
| Normalized Diluted EPS | -0.71 | -1.21 | -1.55 | -1.15 | -1.71 |
| Average Basic Shares Outstanding | 2.50M | 1.63M | 19.56M | 19.49M | 1.22M |
| Average Diluted Shares Outstanding | 2.50M | 1.63M | 19.56M | 19.49M | 1.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |